Clinical Trial: A Study in Subjects With Retinal Detachment

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Double-Masked, Randomized, Dose-Ranging Study of a Single Intravitreal (IVT) Injection of INS37217 Intravitreal Injection in Subjects With Retinal Detachment

Brief Summary: The purpose of this trial is to access the tolerability of INS37217 Intravitreal Injection when administered intravitreally in subjects with macula-on or macula-off rhegmatogenous retinal detachment (RRD).

Detailed Summary:
Sponsor: Merck Sharp & Dohme Corp.

Current Primary Outcome: tolerability

Original Primary Outcome: Same as current

Current Secondary Outcome: pharmacological activity

Original Secondary Outcome: Same as current

Information By: Merck Sharp & Dohme Corp.

Dates:
Date Received: September 13, 2005
Date Started: May 2001
Date Completion:
Last Updated: October 8, 2015
Last Verified: October 2015